GPS Wealth Strategies Group’s Idexx Laboratories IDXX Stock Holding History

GPS Wealth Strategies Group’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-20	Closed	-$12.8K	–	1030
2025 Q3	$12.8K	Hold	20	–	–	﹤0.01%	1033
2025 Q2	$10.7K	Buy	+20	New	+$9.56K	﹤0.01%	1011
2024 Q2	–	Sell	-10	Closed	-$5.4K	–	1381
2024 Q1	$5.4K	Hold	10	–	–	﹤0.01%	984
2023 Q4	$5.55K	Hold	10	–	–	﹤0.01%	964
2023 Q3	$4.37K	Hold	10	–	–	﹤0.01%	993
2023 Q2	$5.02K	Hold	10	–	–	﹤0.01%	990
2023 Q1	$5K	Buy	+10	New	+$4.79K	﹤0.01%	977
2022 Q4	–	Sell	-10	Closed	-$3K	–	571
2022 Q3	$3K	Hold	10	–	–	﹤0.01%	986
2022 Q2	$4K	Sell	10 -9	-47%	-$3.67K	﹤0.01%	924
2022 Q1	$10K	Buy	19 +9	+90%	+$4.73K	﹤0.01%	725
2021 Q4	$7K	Hold	10	–	–	﹤0.01%	802
2021 Q3	$6K	Hold	10	–	–	﹤0.01%	805
2021 Q2	$6K	Hold	10	–	–	﹤0.01%	827
2021 Q1	$4K	Buy	+10	New	+$5.01K	﹤0.01%	792

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JSC

J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GPS Wealth Strategies Group's IDXX Position: Q4 2025 in Review

GPS Wealth Strategies Group sold out of Idexx Laboratories (IDXX) in Q4 2025, closing a stake of 20 shares — an estimated $12.8K sold.

GPS Wealth Strategies Group first reported a position in IDXX in Q1 2021 and held it in 14 quarters. The position peaked at $12.8K in Q3 2025. 1,385 funds tracked by Wall St. Rank hold IDXX as of Q4 2025.

GPS Wealth Strategies Group reported no remaining Idexx Laboratories position as of Q4 2025 after selling out during the quarter.
GPS Wealth Strategies Group sold 20 Idexx Laboratories shares in Q4 2025, an estimated $12.8K.
GPS Wealth Strategies Group first reported a position in Idexx Laboratories in Q1 2021 and held it in 14 quarters.
GPS Wealth Strategies Group's Idexx Laboratories position peaked at $12.8K in Q3 2025.
1,385 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2025.

Based on GPS Wealth Strategies Group's 13F filing for Q4 2025, filed 6 Feb 2026.